Dr Reddy's Laboratories expects a gradual recovery in the current fiscal year after a profit decline last year. Growth in India, Europe, and emerging markets is offsetting pressures in the US business. New product launches and margin improvements are set to support expansion.
The company reported a drop in net profit for the previous fiscal year, primarily due to challenges in its US operations. In contrast, businesses in India, Europe, and emerging markets have demonstrated healthy growth momentum. Officials highlighted that these regions continue to perform well amid the broader recovery efforts.
